The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 05, 2016

Filed:

Oct. 23, 2013
Applicants:

Ubivac, Llc, Portland, OR (US);

Providence Health & Services-oregon, Portland, OR (US);

Inventors:

Traci Hilton, Portland, OR (US);

Sandra Aung, Solana Beach, CA (US);

Rieneke van de Ven, The Hague, NL;

Christopher Paustian, Portland, OR (US);

Tarsem Moudgil, Beaverton, OR (US);

Christopher Dubay, Portland, OR (US);

Christopher Twitty, Solana Beach, CA (US);

Hong-Ming Hu, Portland, OR (US);

Bernard A. Fox, Portland, OR (US);

Assignees:

UbiVac, LLC, Portland, OR (US);

Providence Health & Services-Oregon, Portland, OR (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/39 (2006.01); A61K 39/00 (2006.01); G01N 33/50 (2006.01);
U.S. Cl.
CPC ...
A61K 39/0011 (2013.01); A61K 39/39 (2013.01); G01N 33/505 (2013.01); G01N 33/5047 (2013.01); A61K 2039/55522 (2013.01); A61K 2039/55561 (2013.01);
Abstract

A composition, comprising: an enriched population of autophagosomes derived from a non-small cell lung carcinoma cell line, and wherein the enriched population of autophagosomes includes: one or more toll-like receptor agonists; one or more tumor antigens; and one or more damage-associated molecular pattern molecules. In this way, an off-the-shelf vaccine may be available to be administered in order to stimulate a targeted immune response in patients bearing different tumor types.


Find Patent Forward Citations

Loading…